Zi Long Qian
Vorstandsvorsitzender bei SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Vermögen: 177 726 $ am 30.04.2024
Aktive Positionen von Zi Long Qian
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Vorstandsvorsitzender | 28.10.2022 | - |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Zi Long Qian
Ausbildung von Zi Long Qian
China University of Geosciences | Undergraduate Degree |
Sun Yat-Sen University | Masters Business Admin |
Statistik
International
China | 5 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
Private Unternehmen | 1 |
---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
- Börse
- Insiders
- Zi Long Qian
- Erfahrung